PSA RESPONSE TO NEOADJUVANT ANDROGEN DEPRIVATION THERAPY IS A STRONG INDEPENDENT PREDICTOR OF SURVIVAL IN HIGH-RISK PROSTATE CANCER IN THE DOSE-ESCALATED RADIATION THERAPY ERA

PURPOSE: The aim of the study was to evaluate the prognostic value of prostate specific antigen (PSA) response to neoadjuvant androgen deprivation therapy (ADT) prior to dose-escalated radiation therapy (RT) and long-term ADT in high-risk prostate cancer. METHODS AND MATERIALS: We reviewed the chart...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: McGuire, Sean E., Lee, Andrew K., Cerne, Jasmina Z., Munsell, Mark F., Levy, Lawrence B., Kudchadker, Rajat J., Choi, Seungtaek L., Nguyen, Quynh N., Hoffman, Karen E., Pugh, Thomas J., Frank, Steven J., Corn, Paul G., Logothetis, Christopher J., Kuban, Deborah A.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3840533/
https://ncbi.nlm.nih.gov/pubmed/23102837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2012.08.036
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki